Start Video
Nasri Nahas – CEO of Biopôle Lausanne, 16 Oct 2019

ADC Therapeutics chose Biopôle for its headquarters because it offers a unique combination of good local and international logistical connections, a vibrant community of biotech and medtech companies, and it can accommodate our space and technical requirements as we grow.

Chris Martin – CEO at ADC Therapeutics